Overall Survival Remains Important in Trials of Early-Line Multiple Myeloma Therapy.

Garfall, Alfred; Cohen, Adam; Stadtmauer, Edward; Susanibar-Adaniya, Sandra; Vogl, Dan; Waxman, Adam

Garfall, Alfred; Cohen, Adam; Stadtmauer, Edward; Susanibar-Adaniya, Sandra; Vogl, Dan; Waxman, Adam.

Afiliação

Garfall A; Alfred Garfall, MD, Adam Cohen, MD, Edward Stadtmauer, MD, Sandra Susanibar-Adaniya, MD, Dan Vogl, MD, and Adam Waxman, MD, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Abramson Cancer Center, Perelman School of M
Cohen A; Alfred Garfall, MD, Adam Cohen, MD, Edward Stadtmauer, MD, Sandra Susanibar-Adaniya, MD, Dan Vogl, MD, and Adam Waxman, MD, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Abramson Cancer Center, Perelman School of M
Stadtmauer E; Alfred Garfall, MD, Adam Cohen, MD, Edward Stadtmauer, MD, Sandra Susanibar-Adaniya, MD, Dan Vogl, MD, and Adam Waxman, MD, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Abramson Cancer Center, Perelman School of M
Susanibar-Adaniya S; Alfred Garfall, MD, Adam Cohen, MD, Edward Stadtmauer, MD, Sandra Susanibar-Adaniya, MD, Dan Vogl, MD, and Adam Waxman, MD, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Abramson Cancer Center, Perelman School of M
Vogl D; Alfred Garfall, MD, Adam Cohen, MD, Edward Stadtmauer, MD, Sandra Susanibar-Adaniya, MD, Dan Vogl, MD, and Adam Waxman, MD, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Abramson Cancer Center, Perelman School of M
Waxman A; Alfred Garfall, MD, Adam Cohen, MD, Edward Stadtmauer, MD, Sandra Susanibar-Adaniya, MD, Dan Vogl, MD, and Adam Waxman, MD, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Abramson Cancer Center, Perelman School of M

J Clin Oncol ; 40(1): 106-107, 2022 01 01.

Article em En | MEDLINE | ID: mdl-34652957

Assuntos

Mieloma Múltiplo; Bortezomib; Humanos; Lenalidomida; Mieloma Múltiplo/tratamento farmacológico; Prevenção Secundária

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google